Literature DB >> 3948045

Fentanyl-oxygen versus fentanyl-N2O/oxygen anaesthesia in children undergoing cardiac surgery.

P Crean, G Koren, G Goresky, J Klein, S Macleod.   

Abstract

Fentanyl-oxygen (fentanyl-O2) anaesthesia was compared to fentanyl-nitrous oxide/oxygen (fentanyl-N2O/O2) anaesthesia in 14 children undergoing cardiac surgery. Children were randomly assigned to one of the two techniques studied, with seven patients in each group. The mean age (mean +/- SE) was 3.9 +/- 0.75 years (0.5-8.25 years) and mean weight 14.7 +/- 2 kg (3.5-29.5 kg). Patients were premedicated with IM atropine 0.02 mg . kg-1 and morphine 0.2 mg . kg-1 1 hour preoperatively. They received a fentanyl bolus of 30 micrograms . kg-1 with a concomitant continuous infusion of 0.3 micrograms . kg-1 . min-1. Pancuronium 0.1 mg . kg-1 was administered immediately following the fentanyl bolus. Fifty per cent nitrous oxide was given with oxygen in one group and 100 per cent oxygen was administered to the other group. Fentanyl plasma concentrations were similar in the two groups at the various stages of surgery. There were no significant differences between the two treatment groups in systolic and diastolic blood pressure or in heart rate in response to induction, intubation, and incision. There was a significantly greater increase in systolic blood pressure after sternotomy in the fentanyl-O2 group. In addition, in six of seven patients receiving fentanyl-O2 there were events of sudden increase in blood pressure during various stages of surgery before the bypass, necessitating an additional fentanyl bolus or the addition of droperidol in four cases. Similar phenomena were not documented in the fentanyl-N2O/O2 group. Our studies suggest that fentanyl-O2 anaesthesia in the schedule described, in children undergoing elective cardiac surgery for Tetralogy of Fallot, A-V canal, and transposition of the great arteries, is not sufficient to prevent elevation in systolic blood pressure despite fentanyl plasma concentrations in excess of 20 ng X ml-1. The addition of nitrous oxide prevents this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948045     DOI: 10.1007/bf03010906

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  9 in total

1.  Alfentanil--a kinetically predictable narcotic analgesic.

Authors:  D R Stanski; C C Hug
Journal:  Anesthesiology       Date:  1982-12       Impact factor: 7.892

2.  Infusion model for fentanyl based on pharmacokinetic analysis.

Authors:  J H Hengstmann; H Stoeckel; J Schüttler
Journal:  Br J Anaesth       Date:  1980-10       Impact factor: 9.166

3.  Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery.

Authors:  J G Bovill; P S Sebel
Journal:  Br J Anaesth       Date:  1980-08       Impact factor: 9.166

4.  Gas chromatographic determination of fentanyl and its analogues in human plasma.

Authors:  T J Gillespie; A J Gandolfi; R M Maiorino; R W Vaughan
Journal:  J Anal Toxicol       Date:  1981 May-Jun       Impact factor: 3.367

5.  Fentanyl-air-oxygen anesthesia for ligation of patent ductus arteriosus in preterm infants.

Authors:  S Robinson; G A Gregory
Journal:  Anesth Analg       Date:  1981-05       Impact factor: 5.108

6.  Fentanyl infusion anesthesia for aortocoronary bypass surgery: plasma levels and hemodynamic response.

Authors:  J S Sprigge; J E Wynands; D G Whalley; D R Bevan; G E Townsend; H Nathan; Y C Patel; C B Srikant
Journal:  Anesth Analg       Date:  1982-12       Impact factor: 5.108

7.  Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery.

Authors:  G Koren; G Goresky; P Crean; J Klein; S M MacLeod
Journal:  Anesth Analg       Date:  1984-06       Impact factor: 5.108

8.  Tissue redistribution of fentanyl and termination of its effects in rats.

Authors:  C C Hug; M R Murphy
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

9.  Fentanyl- and sufentanil-oxygen-pancuronium anesthesia for cardiac surgery in infants.

Authors:  P R Hickey; D D Hansen
Journal:  Anesth Analg       Date:  1984-02       Impact factor: 5.108

  9 in total
  3 in total

1.  Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

2.  Nitrous oxide does not exacerbate pulmonary hypertension or ventricular dysfunction in patients with mitral valvular disease.

Authors:  S N Konstadt; D L Reich; D M Thys
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

Review 3.  Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.